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Abstract: Recent advances in retinal stem cell research have raised the possibility that these cells have the potential to be 
used to repair or regenerate diseased retina. Various cell sources for replacement of retinal neurons have been identified, 
including embryonic stem cells, the adult ciliary epithelium, adult Müller stem cells and induced pluripotent stem cells 
(iPS). However, the true stem cell nature of the ciliary epithelium and its possible application in cell therapies has now 
been questioned, leaving other cell sources to be carefully examined as potential candidates for such therapies. The need 
for identification of the ontogenetic state of grafted stem cells in order to achieve their successful integration into the 
murine retina has been recognized. However, it is not known whether the same requirements may apply to achieve 
transplant cell integration into the adult human eye. In addition, the existence of natural barriers for stem cell 
transplantation, including microglial accumulation and abnormal extracellular matrix deposition have been demonstrated, 
suggesting that several obstacles need to be overcome before such therapies may be implemented. This review addresses 
recent scientific developments in the field and discusses various strategies that may be potentially used to design cell 
based therapies to treat human retinal disease. 
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1. INTRODUCTION 
  The irreversible loss of retinal neurons is a common final 
pathway of many ocular diseases, including age-related 
macular degeneration, glaucoma and retinitis pigmentosa. 
Currently there are no therapies available to repair or replace 
damaged retinal cells, prompting investigations to develop 
methods for stem cell transplantation to treat these diseases. 
This review describes the different cell populations that have 
the potential to be used for cell based therapies to regenerate 
the retina, and discusses various factors that need to be 
addressed before cell transplantation can be implemented 
and developed. Cells that could be used as a source of retinal 
neurons for human therapies have been isolated from a 
variety of sources including the embryo and the adult eye. 
Most studies have focussed on the differentiation of 
stem/progenitor cells into photoreceptors, as the 
development of these retinal neurons has been extensively 
characterised. However, little work has been so far 
undertaken on the differentiation of these cells into other 
major type of retinal neurons and this merits further 
investigation. 
2. EMBRYONIC STEM CELLS (ESCs) 
  Embryonic stem cells arise from the eight-cell stage 
morula and are defined as cells that have an unlimited 
capacity for self-renewal and an ability to differentiate into 
any of over 200 cell types in the human body [1]. With their 
plasticity and migratory capacity, ESCs have been proposed 
as ideal candidates for cell based therapies to treat human 
retinal diseases. However, much research is still required in  
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order to differentiate these cells into retinal specific 
precursors. ESCs have been differentiated in vitro into neural 
cell types [2] as well as retinal pigmented epithelium (RPE) 
[3], but controlling their differentiation has proved 
challenging. In the absence of appropriate intracellular 
signals, ESCs appear to differentiate towards a neuronal fate 
by default [4], and although evidence for the production of 
fully functional retinal neurons is lacking, several studies 
suggest that it may be possible to derive photoreceptors from 
ESC cultures. 
  A few groups have reported the induction of a retinal fate 
in mouse embryonic stem cells either using growth factors 
[5, 6], co-culture with explants of embryonic retina [7], or by 
cell insertion of retinal progenitor genes [8]. The most 
efficient induction so far achieved involves the use of growth 
factors that are normally involved in retinal development, 
such as lefty-A, Dkk-1 and Activin-A [5]. This treatment 
caused 25-30% of cells to express the eye-field transcription 
factors Rx and Pax6 and upon co-culture with explants of 
adult mouse retina, they formed rhodopsin and recoverin 
photoreceptors. Other studies have also directed human 
ESCs towards a retinal fate by using a combination of a 
BMP antagonist, a Wnt pathway inhibitor and IGF-1 [9]. 
This protocol resulted in 80% of cells expressing eye-field 
transcription factors and when differentiated up to 10% of 
cells expressed early markers of photoreceptors including 
Crx, Nrl and recoverin. These ESC-derived photoreceptors 
have been shown to restore some visual function in Crx 
deficient mice (a model of Leber’s Congenital Amaurosis) as 
detected by electroretinography [10]. 
  In 2008, a study by Osakada et al. showed expression of 
late photoreceptor markers in differentiated human ESCs, 
although this differentiation involved a 5-6 month protocol 
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pluripotent cells towards a neural fate and later a 
combination of retinoic acid and taurine for retinal 
differentiation, cells expressed functional components for 
light responses including transducin-alpha, phosducin, 
phosphodiesterase and rhodopsin kinase. The differentiation 
of ESCs into other types of retinal neurons has not been 
extensively studied, but emerging new research has shown 
that human ESCs can also be directed towards a retinal 
ganglion cell fate [12]. To achieve this differentiation, ESCs 
were induced to form embryoid bodies and then 
differentiated towards a neuronal fate by culturing cells on 
Poly-L lysine and laminin in the presence of FGF2 and 
serum. Cells were then differentiated for 6 days in the 
presence of FGF2 and Shh. These cells expressed genes 
coding for RGC markers such as ATH5,  BRN3B,  RPF-1, 
THY1 and ISL-1. Unfortunately, only 2% of cells possessed 
these RGC-like properties, and when transplanted 
intravitreally into rats, very few cells integrated into the 
ganglion cell layer [12]. 
  Although studies of ESC differentiation into retinal 
neurons show great promise, there are significant limitations 
to using these cells, including reproducibility of 
differentiation amongst different ESC lines and the risk of 
teratoma formation [13]. In addition, elucidating 
developmental cues that guide the reliable differentiation of 
ESCs towards specific retinal neurons may prove to be a 
very long process. It may therefore be more feasible to use a 
tissue-specific type of stem cell. In this context, 
transplantation of neural stem cells from the adult 
mammalian brain have been shown to be able to integrate 
into the host retina, but have failed to express retinal-specific 
markers [14, 15]. Recently, various populations of 
stem/progenitor cells have been isolated from the adult 
mammalian (including human) neural retina [16] and ciliary 
body [17]. Compared to ESCs, these adult stem cells may be 
easier to differentiate into retinal neurons as they have 
already undergone several processes of differentiation within 
the eye which are unknown to us. Therefore these cells 
would have already undergone crucial stages of development 
to make them committed towards a retinal fate. Their use 
would bypass the long and extensive protocols that may be 
needed to differentiate ESCs into the type of retinal 
progenitors required for efficient retinal transplantation. 
3. STEM/PROGENITOR CELLS FROM THE 
CILIARY EPITHELIUM (CE) 
  The ciliary body is part of the uveal tract that is 
continuous with the iris anteriorly and the choroid 
posteriorly. The ciliary body is lined by an inner non-
pigmented and outer pigmented epithelium, that are 
continuous with the neural retina and retinal pigment 
epithelium respectively. Developmentally, both the ciliary 
epithelium and the retina share a common origin and arise 
from the inner layer of the optic cup [18]. However, they 
follow different fates as demonstrated by their distinct roles 
in the adult eye. The neural retina translates light stimuli into 
neural signals and conveys them to the brain whereas the CE 
secretes aqueous humour to maintain the anterior chamber of 
the eye and thus intraocular pressure. Since the epithelium of 
the ciliary body is derived from the neuroepithelium of the 
optic vesicle during embryonic development, it is thought 
that this region of the eye may contain cells that retain their 
neurogenic potential. This has been suggested by 
observations that the non-pigmented epithelium of the 
chicken eye is capable of generating neurons following 
intraocular injection of growth factors such as insulin, EGF 
and FGF2, which stimulate the proliferation and neuronal 
differentiation of non-pigmented cells within the ciliary body 
of this species [19]. These cells express the transcription 
factors Pax6 and Chx10 and are found around 3mm anterior 
to the peripheral edge of the retina. This region of 
Pax6/Chx10-expressing cells coincides with the region 
where newly generated amacrine cells, Müller glia and 
ganglion cells, but not of bipolar cells or photoreceptors, 
appear in response to growth factor treatment [19]. 
 In  situ studies in the mouse have shown that during 
retinal histogenesis, many rod photoreceptors and their 
precursors can be seen in various stages of morphological 
differentiation in the pars plana (see Fig. 1 for anatomical 
localization). However, once development is complete these 
precursors are rarely seen [20]. In mice with photoreceptor 
degeneration (induced by NMU injections), cells within the 
non-pigmented pars plana were induced to proliferate and 
incorporated BrdU. In addition, some cells also expressed 
recoverin [21]. 
  Neuron-like cells have also been identified in the non-
pigmented epithelium of non-human primates [22, 23]. In the 
monkey ciliary body, cells with a rounded shape showing 
short processes stain for the cone photoreceptor marker 
arrestin. There is also evidence that the human non-
pigmented CE expresses components involved in 
phototransduction including rhodopsin, rhodopsin-kinase 
and arrestin. The presence of photosensitive proteins within 
the CE has led to the suggestion that it plays a role in 
circadian processing [24]. In explants of human retina, a few 
cells within the non-pigmented CE have been shown to 
proliferate in response to EGF [25]. In situ staining of the 
adult human ciliary body has also revealed that non-
pigmented CE cells express SOX2, CHX10 and NOTCH1, 
with characteristic nuclear staining of CHX10 only visible in 
the non-pigmented layer [25]. 
  Cells from the CE expressing stem/progenitor 
characteristics have been isolated and cultured in vitro from 
many species including mice [17], rats [26], pigs [27] and 
humans [28]. Stem cells from the adult mouse ciliary 
epithelium were first reported by Tropepe et al. in 2000. The 
report stated that single “pigmented ciliary margin cells” 
proliferated  in vitro to form sphere colonies of cells 
expressing markers of retinal neurons including rod 
photoreceptors, bipolar cells and Müller glia [17]. This 
inaccurate anatomical description became repeatedly cited in 
the literature, with later reports describing the isolation of 
these cells from the pars plana and pars plicata of the ‘retinal 
ciliary margin’ [27]. In this context, it is important to clarify 
that anatomically both the pars plana and pars plicata are part 
of the ciliary body and not part of the neural retina 
(illustrated in Fig. 1). The pars plana refers to the thin flat 
region of the ciliary body in close proximity to the retinal 
margin whereas the pars plicata refers to the folded region of 
the ciliary body situated between the pars plana and the iris 
[18, 25]. 
  In 2004, the same group that described the presence of 
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human pars plana and pars plicata could be isolated and 
grown as both spheres and monolayers in culture [28]. These 
spheres purportedly consisted of a mixture of both 
pigmented and non-pigmented cells, but no attempt was 
made to dissociate the two cell types. It was then suggested 
that the human eye contains a small population of about 
10,000 retinal stem cells in the CE [28], and that they 
appeared to exist throughout life and in vitro form spheres of 
pigmented and non-pigmented cells within 7 days of 
isolation. When cultured as monolayers and differentiated in 
the presence of FGF2, these cells were shown to express 
markers of progenitor cells such as Nestin, PAX6 and 
CHX10, as well as markers of differentiated cells such as 
rhodopsin and MAP2. Interestingly, some cells also stained 
positive for the RPE marker, RPE 65 [28] and both mouse 
and human CE progenitor cells were found to proliferate 
very rapidly compared to data published for neural stem cells 
[17, 28]. However, when cells dissociated from spheres were 
transplanted into the mouse eye, they showed limited 
migration into the neural retina and RPE [17, 28]. 
  Since the first report of the presence of progenitor/stem 
cells in the mammalian CE, many papers have been 
published characterising these cells and investigating their 
ability to differentiate into retinal neurons. Several groups 
have reported that extended culture of both pigmented and 
non-pigmented cells of the CE causes their differentiation 
into progenitor-like cells [19, 27, 29]. As a result of these 
characteristics, these cells were incorrectly termed ‘retinal 
stem cells’. However, no evidence was presented showing 
that these cells were able to differentiate into functional 
retinal neurons. The relationship between these ‘epithelial’ 
sphere-forming cells and the retinal stem cells in the 
peripheral retina of fish and amphibians is not clear, since 
the latter are not pigmented [30]. However, it may be 
possible that functional variations of CE cells exist amongst 
different species. 
  More recent studies have strengthened the argument that 
CE cells from the mouse and human eye do not possess 
retinal stem cell properties. These investigations have 
demonstrated that CE spheres contain cells with epithelial 
properties and limited expression of neuronal markers 
compared to neurospheres formed by neural stem cells [31, 
32]. Furthermore, investigations have shown that although 
cells isolated from the CE could be induced to express low 
levels of neuronal markers, they retained their epithelial 
morphology and failed to differentiate into retinal neurons 
[31]. These results are supported by in situ observations in 
the human eye that the pigmented ciliary epithelium does not 
express markers of stem/progenitor cells [25]. In summary 
these findings suggest that cells of the CE are not true retinal 
stem cells and therefore may not be suitable for retinal 
regeneration therapies. 
4. STEM CELLS OF THE NEURAL RETINA 
4.1. The Ciliary Marginal Zone 
  In some vertebrates, the development of the retina 
continues throughout life [33]. This is most dramatically 
observed in teleosts where from hatching to final maturation, 
the eye of a teleost fish increases 100 times in size [30]. The 
population of stem/progenitor cells that enables the 
formation of new retinal neurons in this species is found at 
the peripheral margin of the neural retina, where it joins with 
the ciliary epithelium. This area around the peripheral 
margin of the retina is known as the ciliary marginal zone 
(CMZ) [34, 35] (illustrated in Fig. 1). 
  Cells present in the CMZ of fish and amphibians 
resemble the early progenitor cells of the eye, and possibly 
the ‘founder cells’ of the optic vesicle [35]. They can give 
rise to clones that contain all types of retinal neurons, both 
early and late-born, and express the transcription factor 
profile of retinal progenitors [36]. They also respond to 
mitogenic growth factors in a similar way to embryonic 
retinal stem cells [37]. In view of the fact that these cells are 
capable of generating most of the retina in the mature frog 
and fish and continue to generate new retinal neurons 
throughout the life of these animals, it is likely that this 
region contains a population of true retinal stem cells. This 
zone of cells is very active in fish and larval frogs but has 
been shown to be greatly reduced or absent in other 
vertebrate species [34-36]. 
  It was originally thought that birds did not have a CMZ 
since at least 90% of retinal cells are generated a week 
before hatching and therefore have a functional retina at the 
time they hatch. However, it was found that new retinal 
neurons are generated at the peripheral edge of the postnatal 
chick retina up to one month after hatching [38]. Prior to this 
discovery of the CMZ, the relevance of pigmented vs non-
 
Fig. (1). Schematic diagram showing the anatomy of the most anterior neural retina and ciliary body of the adult human eye. A non-
laminated region, similar to that seen in fish and amphibians and known as the ciliary marginal zone (CMZ) is present in fish and amphibians 
throughout life [33-36]. A similar region has been identified in the early postnatal life of avians [38] and rodents [55], as well as in young 
primates [22] and human adults [25]. 
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pigmented cells from this region of the chick retina for in 
vitro regeneration of retinal tissue was identified by Layer et 
al. [39-41], and their studies suggested that stem cells were 
localized in this part of the retina [42]. This CMZ-like region 
has also been found in the quail [43]. Chick CMZ cells 
express a number of different genes present in embryonic 
retinal progenitor cells including Pax6, Chx10, PCNA and 
Notch1, and can be stimulated by a combination of FGF2 
and insulin [38]. Although this CMZ-like zone has 
similarities with the CMZ of fish and amphibians, the CMZ 
of chicks at first appeared to generate only amacrine and 
bipolar cells. However, addition of FGF2 and insulin 
stimulated the production of ganglion cells, suggesting that 
the types of cells produced by the avian CMZ may be 
influenced by the microenvironment rather than by cell-
intrinsic programming. Unlike that seen in cold-blooded 
vertebrates, the CMZ progenitors of the chick do not 
increase their rate of proliferation in response to acute 
cytotoxic damage [38]. However, the proliferation of cells in 
the normal post-hatch chicken can be increased by 10-fold 
by intraocular delivery of growth factors including insulin, 
insulin-like growth factor 1, epidermal growth factor (EGF), 
and sonic hedgehog (Shh) but not fibroblast growth factor 
(FGF) [38]. In addition to these growth factors the number of 
BrdU-positive cells in the CMZ can be doubled by visual 
deprivation of post-hatch chicks [38]. 
  In warm blooded vertebrates, retinal histogenesis is 
thought to occur only during the early stages of development 
and the retina is believed to stop growing well before the 
animal has reached adulthood. There is a possibility that 
mammals may have some form of CMZ although a 
proliferating ciliary margin may prove difficult to 
demonstrate in the adult human eye. A rudimentary CMZ 
has been found in newborn opossums showing that these 
marsupials share some similarities with birds and reptiles 
[43]. There is also evidence that the retina of young primates 
exhibits a CMZ-like region [22] and studies have shown that 
an increased number of progenitor cells in this region is 
observed in adult mice expressing only a single functional 
allele of the sonic hedgehog receptor patched [44]. 
  The possibility that an active CMZ-like region exists in 
the adult mammalian eye is currently an area of growing 
research interest and reports of the expression of the 
intermediate filament protein Nestin (a marker of stem cells) 
by cells present in the most peripheral region of primate and 
human retina, suggest the presence of progenitor cells in 
these species [23, 25, 45]. Electron microscopy of the non-
laminated peripheral retina of monkeys has shown 
photoreceptor cells in seemingly different stages of 
morphological differentiation [23], further supporting the 
suggestion that primate retina may contain a population of 
stem cells located in the non-laminated peripheral retina. 
Moreover, in situ analysis of the adult human retina has also 
shown that Nestin positive cells present in the most 
peripheral neural retina co-express the Müller glial cell 
marker CRALBP (Fig. 2). These cells lack of lamination and 
are characteristically assembled in bundles resembling glia. 
They also express markers of neural retinal stem/progenitor 
cells, including CHX10, SOX2 and SHH, suggesting a 
region analogous with the CMZ of fish and amphibians [25]. 
Although these cells appeared to be quiescent, culture of 
retinal explants with epidermal growth factor caused 
significant cell proliferation in this region as determined by 
the proliferation antigen Ki67 [25]. 
4.2. Müller Glia as a Source of Retinal Stem Cells 
  The possibility of neural regeneration in the brain from 
glial cells has gained support over recent years. It has been 
demonstrated that radial glia function as stem cells in the 
developing mammalian central nervous system (CNS) and 
that they produce new neurons and glia [46]. Other studies in 
the adult mammalian brain show that astrocyte-like cells 
may be the neural stem cells in the subventricular zone and 
hippocampus [47]. These neural stem cells do not have the 
morphology of undifferentiated stem cells, but exhibit 
features of differentiated astrocytes at the ultrastructural and 
molecular levels including the expression of GFAP [48]. 
Recently, it has also been shown that Bergmann glia in the 
cerebellum of the adult mouse brain express the neural stem 
cell markers Sox1 and Sox2 [49]. Put together, the above 
evidence suggest that glial cells within the retina may play a 
similar role to that ascribed to glia within the CNS. 
  Müller glia are the main glial cells of the retina [50]. 
They span the entire length of the retina and perform many 
of the functions carried out by astrocytes, oligodendrocytes 
and ependymal cells in other regions of the CNS [50]. 
Müller cells have been shown to share a lineage with retinal 
neurons and to derive from a common progenitor that is 
multipotent at all stages of retinal histogenesis [51]. This was 
proved by examining the progeny of a single rat retinal 
progenitor cell transfected with a retrovirus in the postnatal 
retina. This generated clones which produced up to three 
types of retinal neurons, whilst other clones contained a 
combination of neurons and Müller glia [51]. It has been 
suggested that Müller glia may function in a way similar to 
radial glia in the brain during late development and that they 
may possess a latent neuroregenerative capacity. Studies in 
the zebrafish have shown that all Müller glia in the retina 
express low levels of the multipotent progenitor marker Pax6 
and that they proliferate at a low frequency in the intact, 
uninjured retina [51]. Müller glia-derived progenitors 
generate cells that follow the rod photoreceptor lineage in the 
post-embryonic fish retina [52]. In addition, Müller glia-
derived progenitors also remain competent to produce earlier 
neuronal lineages and respond to loss of cone photoreceptors 
by specifically regenerating missing neurons in this species 
[53]. 
  It may be possible that growth factors produced by 
damaged cells in the retina cause a population of Müller glia 
to dedifferentiate, proliferate and become progenitor-like 
cells in all vertebrates. Fischer et al. [54] showed that 
injection of insulin and FGF2 into the post-natal chick retina 
caused Müller glia to co-express transcription factors 
common to retinal progenitors including Pax6 and Chx10. 
Müller cells in the post-natal chick also re-entered the cell 
cycle in response to damage induced by N-methyl-D-aspartic 
acid (NMDA) [55]. This was shown by findings that a few 
days after treatment with this neurotoxic agent, Müller cells 
began to express markers of retinal neurons such as HuD, 
calretinin and CRALBP. In the neonate rat retina, Müller 
glia have also been shown to constitute a potential source for 
the regeneration of retina in this species [56]. Similar to 
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and damage to the rat retina. In response to this treatment, 
Müller glial cells were stimulated to proliferate and to 
produce new neurons. However, a larger number of 
regenerated neurons could be produced by treatment with 
retinoic acid or by mis-expression of the homeobox and 
basic helix-loop-helix genes [55]. Müller cells isolated from 
the rat retina have also been cultured in vitro and have been 
shown to self renew and express markers of retinal neurons 
[56]. 
  A sub-population of Müller glia with stem/progenitor 
characteristics has also been identified in situ within the 
adult human retina [16, 25]. In situ, these cells not only 
express characteristic Müller glial markers, such as 
CRALBP and Vimentin, but also neural progenitor markers 
such as Nestin, CHX10, SOX2 and NOTCH1 [25] (Fig. 3). 
Müller cells with stem cell characteristics (known as Müller 
stem cells) have been isolated from the human retina and 
have been shown to be capable of proliferating indefinitely 
in vitro [16]. These observations followed the description of 
a spontaneously immortalised human Müller cell line MIO-
M1 (Moorfields/Institute of Ophthalmology-Müller 1) in 
2002 [57] and further work revealed that these cells and 
other similar cell lines obtained from different post-mortem 
retinae (known as the MIO cell lines) express stem cell 
markers  in vitro [16]. Levels of expression of progenitor 
markers were shown to vary according to the presence or 
absence of extracellular matrix and of growth and 
differentiation factors used to culture these cells [16]. Upon 
activation with various factors, these cells adopt a neuronal 
morphology (Fig. 3) and express markers of post-mitotic 
retinal neurons including peripherin, recoverin, calretinin, 
and S-opsin. Although their migration is poor when grafted 
into the subretinal space of dystrophic RCS rats or neonate 
Lister hooded rats, cells that migrate into the different retinal 
layers express various markers of retinal neurons [16]. These 
observations suggest that human Müller stem cells, which   
 
can be easily isolated and grown from cadaveric retinae, may 
have the potential to generate functional retinal neurons and 
therefore may be used in cell based therapies to treat retinal 
diseases. 
5. INDUCED PLURIPOTENT STEM (IPS) CELLS 
  The recent advent of iPS cells has opened a new potential 
avenue in the pursuit of cells for transplantation in 
regenerative medicine. Takahashi & Yamanaka [58] 
demonstrated that by retroviral induction of Oct3/4, Sox2, c-
Myc and Klf4 pluripotent stem cells could be obtained from 
fibroblast cultures. Further study of these “reprogrammed” 
iPS cells revealed that their biological behaviour was 
indistinguishable from that of ESCs [59]. Recent refinements 
to the technique have enabled iPS cell generation without the 
use of viral vectors [60] and without induction of c-Myc [61] 
which is associated with an increase in tumorigenesis. 
However before such cells can be taken through to clinical 
trials, concerns regarding the effect of the reactivation of 
pluripotency upon a cell, alterations in target cells and 
characterisation of the cells need to be addressed [62]. 
  The study of early human retinal development has been 
limited to comparative studies in other species and more 
recently to ESCs. It has been shown that iPS cells can also 
undergo a targeted differentiation process towards 
retinogenesis and have the ability to provide a further in vitro 
model of the developing human retina [63]. Both mouse and 
human IPS cells have been induced to differentiate into 
retinal progenitor cells in vitro [64]. Subsequent treatment of 
these iPS derived progenitors with retinoic acid and taurine 
resulted in cells expressing markers of photoreceptors, thus 
raising the possibility of an alternative source of 
photoreceptor progenitors for transplantation. 
  Although the field of iPS cell research is rapidly 
evolving, it needs further refinement before development of  
 
 
 
Fig. (2). Expression of neural progenitor markers in the non-laminated region (ciliary margin-like zone) of the adult human retina. 
(A) Confocal image of adult human retina showing intense expression of Nestin (green) in the most peripheral region adjacent to the ciliary 
body (asterisk). Pigmented (solid arrow) and non-pigmented (segmented arrow) ciliary epithelium do not express Nestin in situ [25]. (B) 
Confocal image of non-laminated anterior retina showing expression of the Müller cell marker CRALBP (green) and the progenitor marker 
CHX10 (red). 
Nestin                                                          CRALBP/CHX10 A.                                                                    B.
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autologous cell based therapies for retinal disease can be 
safely developed. 
6. IMPROVING THE SUCCESS OF STEM CELL 
TRANSPLANTATION 
  Transplantation of stem and progenitor cells to regenerate 
the CNS is a subject of continuous investigations. Proposed 
mechanisms of therapeutic efficacy include neuroprotection 
of surviving cells [65] and/or retinal replacement [66]. 
However, various studies have identified a series of natural 
barriers that need to be overcome before these therapies can 
be brought to the clinic. Two of the major problems facing 
the development of stem cell therapies in the CNS is the 
presence of extracellular matrix molecules that prevent the 
outgrowth of axons and the low efficiency with which stem 
cells migrate and integrate into the retina. This has been 
shown by observations that when neural stem cells are 
transplanted into an injured spinal cord, most of the cells 
remain in the cavity wall and do not migrate or integrate 
with the host spinal cord [67]. In the eye, photoreceptors 
have been transplanted into the degenerating retina, but these 
attempts have resulted in little evidence of host-graft 
synaptic formation and functional recovery [68-70]. Studies 
involving retinal transplantation have shown that when a 
small number of cells integrate, they produce a short term 
improvement of function but are not sufficient to regenerate 
the diseased retina [10]. These findings have led researchers 
to investigate factors that may be potentially modified to 
improve the migration and integration of retinal stem cells. 
These include studies into the modulation of the extracellular 
matrix and the identification of the most appropriate 
ontogenetic stage at which transplanted cells will optimally 
integrate into the retina. 
6.1. Modulating the Extracellular Matrix (ECM) 
  In the retinal field, there is increasing awareness of the 
environmental changes that occur in response to 
degeneration, trauma or surgical manipulation. These 
processes have been found to induce reactive gliosis and to 
increase to the production of chondroitin sulphate 
proteoglycans (CSPGs) in the ECM. In turn, deposition of 
CSPGs has been shown to inhibit regeneration of the injured 
rat optic nerve [71]. These proteins are well known to inhibit 
axonal regeneration in the CNS [72] and have been 
identified within the retina during development, where 
CSPGs defines the pathway of neurons by creating borders 
[73]. More recent studies have shown that deposition of 
abnormal ECM proteins promote the formation of glial 
scarring in the retina. This creates a non-permissive 
environment for the migration of transplanted retinal or 
retinal progenitor cells into the host retina [74]. This glial 
scarring forms a physical and chemical barrier that has been 
shown to prevent transplanted cells from integrating with the 
host retina [74, 75]. These observations suggest that the 
success of transplantation into the retina may lie in the 
modulation of the ECM. 
  Degradation of CSPGs using the enzyme chondroitinase 
ABC (ChABC) has been shown to enhance neurite 
outgrowth and axon regeneration in both the injured brain 
and spinal cord [67, 76, 77]. Treatment with ChABC at the 
site of spinal cord injury degrades CSPGs and upregulates 
expression of regeneration-associated proteins in injured 
 
Fig. (3). A population of Müller glia from the adult human retina express neural stem cell characteristics in vitro. (A) Cells cultured in 
the absence of extracellular matrix and growth factors display a characteristic glial morphology. In contrast, cells cultured in the presence of 
extracellular matrix and FGF2 for 5 days acquire a neural morphology with characteristic axon-like processes (red arrows). (B) Müller stem 
cells in culture express the retinal progenitor markers CHX10, SOX2 and intermediate filament nestin. 
Control                                       + FGF2                                      
A.
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neurons, resulting in the restoration of post-synaptic activity 
below the lesion and promotion of behavioural recovery 
[76]. In the retina, it has been shown that the efficiency of 
cell transplantation can be increased by using enzymes 
which degrade components of the extracellular matrix. 
ChABC has been found to improve the migration and 
integration of retinal progenitors transplanted into the 
degenerating mouse retina [75], and further studies have 
shown that the migration and integration of transplanted 
human Müller stem cells into the degenerating RCS rat 
retina could be improved by the injection of ChABC to 
degrade CSPGs, together with immuno-suppression to 
control the microglial response [74]. Another enzyme that 
has been used to modulate the ECM in order to facilitate 
migration and integration of transplanted cells into the retina 
is the matrix metalloproteinase 2 (MMP-2). Addition of 
active MMP-2 to retinal explants has been shown to increase 
the migration of transplanted retinal progenitor cells [78]. 
6.2. Defining the Optimal Ontogenetic Stage of Stem 
Cells before Transplantation 
  A number of studies have found that although neural 
stem cells are able to migrate into the host retina, they do not 
express retinal phenotypes. Conversely, retinal stem cells are 
able to differentiate but are unable to migrate and integrate 
with the host retina [68, 70]. This could be due to the adult 
retinal environment being unable to provide the complex and 
numerous signals needed for retinal neuronal development. 
Recent work has shown that mouse donor cells are able to 
integrate into the photoreceptor layer of the adult or 
degenerating mouse retina if they are rod precursors and 
express the transcription factor NRL (neural retina leucine 
zipper) which is associated with terminal differentiation 
towards a photoreceptor fate [79]. This suggests that stem 
cells may need to be directed towards a post-mitotic 
photoreceptor ‘progenitor phenotype’ in vitro before 
transplantation in order to achieve optimal integration and 
functionality. A recent study has also highlighted the 
importance of transplanting post-mitotic cells into the eye. 
When ESCs were transplanted into a degenerating mouse 
model they formed teratomas within 6 weeks after 
transplantation, causing severe disruption of the retinal 
structure [80]. Interestingly, cells differentiated as neural 
progenitors before transplantation showed slower migration 
into the retina and did not cause tumour formation [80]. 
CONCLUSIONS 
  Although studies in the retinal stem cell field have led to 
the identification of various cell sources and methods to 
improve transplant cell migration and integration, much 
work is still needed before cell based therapies can be 
implemented to treat human retinal disease. Present 
knowledge would suggest that the development of stem cell 
therapies may be a viable proposition in the not too distant 
future, and efforts should be made to design practical 
approaches to source the most appropriate stem cells and to 
develop transplantation strategies that promote the long term 
functional integration of these cells into the diseased retina. 
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